Assigned to HHS                                                                                                                     FOR COMMITTEE

 


 

 

 


ARIZONA STATE SENATE

Fifty-Fourth Legislature, First Regular Session

 

FACT SHEET FOR S.B. 1026

 

school pupils; emergency medication administration

Purpose

            Permits a public or charter school district employee to administer certain medications, in the case of an emergency, to a minor without request or authorization of the minor's parent or legal guardian.

Background

            Statute grants school district governing boards and charter school governing bodies the authority to establish policies and procedures that govern the administration of prescription medications or patent or proprietary medications to students by district employees (A.R.S. § 15‑344). If the student is a minor, medication may only be administered upon the request or authorization of the student's parent or legal guardian.

            Current statute allows an employee of a school district or charter school to administer specified medications in the following circumstances, if the employee is trained in the administration of the medication: 1) epinephrine auto-injectors, if the employee in good faith believes that the child is exhibiting symptoms of anaphylactic shock; 2) inhalers, if the employee in good faith believes that the child is exhibiting symptoms of respiratory distress; and 3) naloxone hydrochloride or any opioid antagonist, if the employee in good faith believes that the child is exhibiting symptoms of opioid-related overdose (A.R.S. §§ 15-157; 15-158; and 15-341).

            There is no anticipated fiscal impact to the state General Fund associated with this legislation.

Provisions

1.      Allows an employee of a public or charter school district to administer epinephrine auto‑injectors, naloxone and inhalers to a minor child without consent of a parent or guardian in the case of an emergency.

2.      Makes technical changes.

3.      Becomes effective on the general effective date.

Prepared by Senate Research

January 17, 2019

CRS/AG/gs